7Baggers
 gene therapy media market is booming worldwide| sarepta  openPR.com Thu, 06 Nov 2025 07:16:47 GMT
 beta-thalassemia (b-thal) market exclusive report with  openPR.com Tue, 04 Nov 2025 06:28:31 GMT
 united states cancer gene therapy market 2025: industry  openPR.com Thu, 30 Oct 2025 09:41:50 GMT

bluebird bio, Inc
(NASDAQ:BLUE) 

BLUE stock logo

bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases and cancer. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent -thalassemia; Len...

Founded: 1992
Full Time Employees: 1,171
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends